Fred’s Completes Sale of Specialty Pharmacy Unit

We represented Fred’s, Inc. (Nasdaq: FRED) in its sale of the assets of EntrustRx, a specialty pharmacy unit, to CVS Health Corporation for $40 million and the subsequent closing of the pharmacy operations. This transaction was an important step in Fred’s plans to monetize non-core assets as part of its broader turnaround efforts.

Fred’s, Inc., headquartered in Memphis, Tennessee, operates approximately 600 general merchandise and pharmacy stores, including 12 franchised locations.

You Also May Be Interested In:

  • Representing the independent Special Committee of Strategic Storage Growth Trust, Inc. (SSGT), in its definitive agreement to merge with Strategic Storage Trust II, Inc., (SST II) in an all-cash merger valued at $340 million expected to close during the first quarter of 2019, subject to customary closing conditions, including the approval of SSGT’s stockholders

    We are representing the independent Special Committee of Strategic Storage Growth Trust, Inc. (SSGT), in its definitive agreement to merge...
    Client Type: Private Company
  • Represented Wright Medical Group in its acquisition of Cartiva, Inc.

    We served as lead counsel to Wright Medical Group N.V. (Nasdaq: WMGI) in the acquisition of Cartiva, Inc., a privately-held...
    Client Type: Public Company
  • We represented NN, Inc. (Nasdaq: NNBR) in its public offering of 14,375,000 shares of common stock, which was composed of...
    Client Type: Public Company